
After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Anjali Kulthe, the staff nurse who saved many lives in the 26/11 Mumbai attack, shared her grief
One in Gujarat and the other in Udaipur. The meaning of the name of both is the same. One Kishan,
Indian cricketer Yuzvendra Chahal celebrated his 35th birthday on Wednesday. On this occasion, he
PM Modi post-budget webinar: Prime Minister Narendra Modi is addressing a post-budget (post-budge
Former Australia captain Ricky Ponting has worked closely with Team India's wicket-keeper batsman
Only a few hours are left for the counting of votes for the Lok Sabha elections in 2024. The coun
For the past few years, the US has accused China of making developing countries more dependent on
CEE KEAM 2023 Rank List Out: The Commissioner of Entrance Examinations (CEE) Kerala has published
Sakoli constituency is a famous assembly constituency of Bhandara district. State Congress Presid
Elon Musk said- New X users will have to pay money for tweeting, know the reason behind this
Elon Musk and his social media platform X, which is constantly in the news, have recently announc